RAPT Therapeutics and Hanmi Pharmaceutical Announce Collaboration to Develop and Commercialize FLX475 in Asia

RAPT Therapeutics and Hanmi Pharmaceutical Announce Collaboration to Develop and Commercialize FLX475 in Asia

Ads

You May Also Like

Arbutus Announces Corporate Update and Third Quarter 2017 Financial Results

Strategic Investment from Roivant Extends Cash RunwayCombination Study for ARB-1467 Starting in 4Q17Company to ...

ThromboGenics Business Update – FY 2017

Press release                                                          15 March 2018Regulated Information Advancing Preclinical and Clinical Diabetic Eye Disease Portfolio ...